SecBot SecBot
SC 13G/A ·Filed Oct 7, 2026

LFMD

LifeMD, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed20d 4h ago SEC0001623632-26-001552
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion to Schedule 13D, which would signal activist intent. For now, Federated Hermes remains a passive holder with no change in position.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
LFMD ▼ -15.05% at T+5d
NEUTRAL call -15.05% · α vs SPY -14.07% · entry $2.79 → $2.37
Next anchor: T+20d in 8d
Latest observation: T+12 -15.12% FF3 residual α
Entry = T+0 close
Oct 7, 2026
via day close
T+1d
-5.02%
call -5.02% · α -4.59%
$2.65
settled 19d ago
T+5d
-15.05%
call -15.05% · α -14.07%
$2.37
settled 13d ago
T+20d
Pending
in 8d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Federated Hermes, Inc. filed an amendment to its Schedule 13G, reporting beneficial ownership of 4,049,974 shares of LifeMD, Inc. common stock as of September 30, 2026, representing an 8.4% stake. This is a routine passive ownership update with no change in position disclosed relative to the prior filing; the filing confirms continued passive investment without activist intent.

Key Financial Metrics

Stake
8.4%
Investor
Federated Hermes, Inc.

Key Facts

  • Federated Hermes, Inc. reported beneficial ownership of 4,049,974 shares of LifeMD common stock as of September 30, 2026.
  • The stake represents 8.4% of LifeMD's outstanding shares.
  • The filing is an amendment to Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
  • No change in stake size or percentage was provided in the filing documents compared to the prior filing.
  • The reporting persons expressly disclaim beneficial ownership of the securities held by managed funds.

Financial Impact

No financial impact; passive stake disclosure only.

Risk Factors

  • No material risks identified from this routine passive stake amendment.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001623632-26-001552
Document: lifemdexhibit1.htm0001623632-26-001552
Document: lifemdexhibit3trd.htm0001623632-26-001552
Document: lifemdexhibit3acd.htm0001623632-26-001552
Document: 0001623632-26-001552-index-headers.html0001623632-26-001552
Document: 0001623632-26-001552-index.html0001623632-26-001552
Document: 0001623632-26-001552.txt0001623632-26-001552
7 reports for LFMD
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for LFMD — sortable, filterable
TypeNow
Oct 7, 2026
20d ago
SC 13G/A
NEUTRAL ★ 3/10
$2.79awaiting T+20—$2.15 (−22.76%)
Sep 22, 2026
4w ago
Press Release
NEUTRAL ★ 2/10
$3.05 $2.14▼ −29.84%▼ −30.52%$2.15 (−29.34%)
Aug 5, 2026
11w ago
Press Release
BEARISH ★ 7/10
$3.40 $3.05▲ +10.29%▲ +10.89%$2.15 (+36.62%)
Apr 27, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$4.57 $4.24▼ −7.22%▼ −12.18%$2.15 (−52.84%)
Mar 31, 2026
30w ago
Press Release
NEUTRAL ★ 4/10
$3.61 $4.43▲ +22.71%▲ +13.29%$2.15 (−40.30%)
Mar 24, 2026
30w ago
Press Release
NEUTRAL ★ 3/10
$3.90 $4.54▲ +16.41%▲ +8.55%$2.15 (−44.74%)
Mar 9, 2026
33w ago
Press Release
BULLISH ★ 8/10
$3.91 $3.47▼ −11.25%▼ −11.10%$2.15 (−44.88%)
Showing 7 of 7

US Market Status

Market Open — Closes in 4h 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 7, 2026